Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.42 CHF | +1.26% | +1.47% | +19.55% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Transcripts